Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,678,894
in 11 filings, $1.7M under 10b5-1 plans

Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-11-22 Pieper Steven See Remarks Option exercise · Stock Option (Right to Buy) −16,843 0
2024-11-22 Pieper Steven See Remarks Option exercise · Stock Option (Right to Buy) −2,640 0
2024-08-12 Schmid John P. Director Purchase +4,515 $2.25 $10K 25,200
2024-08-09 Schmid John P. Director Purchase +4,285 $2.37 $10K 20,685
2024-08-01 Shannon John Patrick Jr See Remarks Grant or award +250,000 2,419,612
2024-08-01 Shannon John Patrick Jr See Remarks Grant or award · Stock Appreciation Right +300,000 300,000
2024-08-01 McCulloch Kevin See Remarks Grant or award +150,000 1,601,953
2024-08-01 McCulloch Kevin See Remarks Grant or award · Stock Appreciation Right +200,000 200,000
2024-07-28 Pieper Steven See Remarks Shares withheld for taxes −14,767 $2.61 $39K 1,422,337
2024-06-05 Schmid John P. Director Grant or award +50,000 113,159
2024-06-05 Fairley Ricki Louise Director Grant or award +50,000 135,000
2024-06-05 SHERMAN JEFFREY W Director Grant or award +50,000 164,380
2024-06-05 BORMANN-KENNEDY BARBARA-JEAN ANNE Director Grant or award +50,000 107,500
2024-06-05 JOHNSON JOHN Director Grant or award +50,000 890,983
2024-06-05 PERSKY MARLA Director Grant or award +50,000 107,500
2024-06-05 Kong Garheng Director Grant or award +50,000 164,144
2024-06-05 HALKUFF DAWN Director Grant or award +50,000 107,500
2024-05-10 Schmid John P. Director Purchase +5,400 $1.91 $10K 16,400
2024-03-18 JOHNSON JOHN Director Option exercise +215,600 $1.99 $429K 751,412
2024-03-18 JOHNSON JOHN Director Option exercise · Stock Option (Right to Buy) −215,600 0

Page 8 of 10 · 200 trades